progression

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

Source Node:
Time Stamp: March 14, 2025 2:33 PM - Modified On: March 14, 2025 - Published By:
Source Cluster:
Republished By Plato

Interim Analysis Expected End of 2Q 2025 BETHESDA, Md., March 13, 2025 -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced the dosing of the first participant with Parkinson’s disease (PD) in its Phase 1b clinical trial of GT-02287, the Company’s lead allosteric small molecule in development for the treatment of PD with or without a GBA1 mutation. “Initiation of dosing in our Phase 1b clinical trial represents an

Star Teen Filipino Race Driver Bianca Bustamante Unveils NFT Project to Achieve her F1 Dream

Source Node:
Time Stamp: May 12, 2022 2:18 PM - Modified On: May 12, 2022 - Published By:
Source Cluster:
Republished By Plato

Launches groundbreaking project, "The Dark Horse" NFT Access Pass, to support basic living and training costsInclusive community offers fans unprecedented insight into her journey up the global racing ladderHer NFT Access Pass includes behind-the-scenes content; additional drops and airdrops; plus future prize pools planned MANILA, May 12, 2022 - (ACN Newswire) - Bianca Bustamante, a 17 year-old rising motorsport star from the Philippines, announced that she is launching a groundbreaking project, The Dark Horse - an NFT Access Pass that redefines the career progression of young athletes by embracing technology,